MedElevator Войти в исследования
← Поиск публикаций
Медицинская библиотека · The Israel Medical Association journal : IMAJ · 2011

Effects of adalimumab treatment on vascular disease associated with early rheumatoid arthritis.

Kerekes György, Soltész Pál, Szucs Gabriella, Szamosi Szilvia, Dér Henriett, Szabó Zoltán, Csáthy László, Váncsa Andrea, Szodoray Peter, Szegedi Gyula, Szekanecz Zoltán

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Increased cardiovascular morbidity has become a leading cause of mortality in rheumatoid arthritis (RA). Tumor necrosis factor-alpha (TNFa) inhibitors may influence flow-mediated vasodilation (FMD) of the brachial artery, common carotid intima-media thickness (ccIMT) and arterial stiffness indicated by pulse-wave velocity (PWV) in RA.

OBJECTIVES

To assess the effects of adalimumab treatment on FMD, ccIMT and PWV in early RA.

METHODS

Eight RA patients with a disease duration < or =1 year received 40 mg adalimumab subcutaneously every 2 weeks. Ultrasound was used to assess brachial FMD and ccIMT. PWV was determined by arteriograph. These parameters were correlated with C-reactive protein, vonWillebrand factor (vWF), immunoglobulin M (IgM)-rheumatoid factor (RF), anti-CCP levels and 28-joint disease activity score (DAS28).

RESULTS

Adalimumab therapy successfully ameliorated arthritis as it decreased CRP levels (P = 0.04) and DAS28 (P < 0.0001). Endothelial function (FMD) improved in comparison to baseline (P < 0.05). ccIMT decreased after 24 weeks, indicating a mean 11.9% significant improvement (P = 0.002). Adalimumab relieved arterial stiffness (PWV) after 24 weeks. Although plasma vWF levels decreased only non-significantly after 12 weeks of treatment, an inverse correlation was found between FMD and vWF (R = -0.643, P = 0.007). FMD also inversely correlated with CRP (R = -0.596, P= 0.015). CRP and vWF also correlated with each other (R = 0.598, P = 0.014). PWV and ccIMT showed a positive correlation (R = 0.735, P = 0.038).

CONCLUSIONS

Treatment with adalimumab exerted favorable effects on disease activity and endothelial dysfunction. It also ameliorated carotid atherosclerosis and arterial stiffness in patients with early RA. Early adalimumab therapy may have an important role in the prevention and management of vascular comorbidity in RA.

Для цитирования: Kerekes György, Soltész Pál, Szucs Gabriella, Szamosi Szilvia, Dér Henriett, Szabó Zoltán, Csáthy László, Váncsa Andrea, Szodoray Peter, Szegedi Gyula, Szekanecz Zoltán. Effects of adalimumab treatment on vascular disease associated with early rheumatoid arthritis.. The Israel Medical Association journal : IMAJ. 2011.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.